Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-18

FDA Approved: ILUVIEN — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application from ANI Pharmaceuticals to add a new manufacturer for ILUVIEN (fluocinolone acetonide) under the existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ILUVIEN (fluocinolone acetonide)

Snippet

SUPPL AP for ILUVIEN (FLUOCINOLONE ACETONIDE)